MassMutual Private Wealth & Trust FSB lifted its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 5,143.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 57,944 shares of the scientific and technical instruments company's stock after purchasing an additional 56,839 shares during the period. MassMutual Private Wealth & Trust FSB's holdings in Cognex were worth $3,514,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in CGNX. Versant Capital Management Inc grew its position in shares of Cognex by 16.9% during the 3rd quarter. Versant Capital Management Inc now owns 9,497 shares of the scientific and technical instruments company's stock worth $576,000 after purchasing an additional 1,376 shares in the last quarter. Marathon Mission Inc. increased its holdings in shares of Cognex by 22.4% during the third quarter. Marathon Mission Inc. now owns 4,613 shares of the scientific and technical instruments company's stock worth $280,000 after purchasing an additional 845 shares during the period. QRG Capital Management Inc. acquired a new stake in shares of Cognex in the second quarter valued at approximately $214,000. Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Cognex in the second quarter valued at approximately $268,000. Finally, IPG Investment Advisors LLC acquired a new stake in shares of Cognex in the second quarter valued at approximately $313,000. 88.12% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CGNX has been the topic of a number of analyst reports. Weiss Ratings raised Cognex from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, August 11th. Barclays reaffirmed an "overweight" rating and issued a $80.00 price objective (up from $75.00) on shares of Cognex in a report on Monday, August 10th. Zacks Research upgraded Cognex from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, June 16th. Cantor Fitzgerald increased their target price on Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a report on Friday, August 7th. Finally, Robert W. Baird decreased their price target on Cognex from $78.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, September 23rd. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $75.21.
Check Out Our Latest Stock Report on CGNX
Cognex Stock Performance
Cognex stock opened at $64.37 on Tuesday. Cognex Corporation has a 52 week low of $34.60 and a 52 week high of $72.88. The stock has a market capitalization of $10.83 billion, a P/E ratio of 62.50 and a beta of 1.48. The stock has a fifty day moving average of $62.07 and a 200-day moving average of $61.00.
Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.03. The business had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.Cognex's revenue was up 16.9% compared to the same quarter last year. During the same period last year, the firm posted $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, research analysts forecast that Cognex Corporation will post 1.68 earnings per share for the current year.
Cognex Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Thursday, August 20th were issued a dividend of $0.0850 per share. The ex-dividend date of this dividend was Thursday, August 20th. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex's payout ratio is 33.01%.
About Cognex
(
Free Report)
Cognex Corporation NASDAQ: CGNX develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.
The company's product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.
Featured Stories
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.